nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—head and neck cancer	0.338	1	CiPCiCtD
Capecitabine—esophageal cancer—head and neck cancer	0.131	0.595	CtDrD
Capecitabine—DPYD—head and neck cancer	0.129	0.644	CbGaD
Capecitabine—stomach cancer—head and neck cancer	0.0891	0.405	CtDrD
Capecitabine—DPYD—Fluorouracil—head and neck cancer	0.086	0.489	CbGbCtD
Capecitabine—TYMS—head and neck cancer	0.0713	0.356	CbGaD
Capecitabine—TYMP—Fluorouracil—head and neck cancer	0.0572	0.325	CbGbCtD
Capecitabine—TYMS—Fluorouracil—head and neck cancer	0.0304	0.173	CbGbCtD
Capecitabine—CYP2C9—Fluorouracil—head and neck cancer	0.00241	0.0137	CbGbCtD
Capecitabine—TYMP—Pyrimidine catabolism—DPYD—head and neck cancer	0.00132	0.056	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00124	0.0526	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.0011	0.0469	CbGpPWpGaD
Capecitabine—CES1—larynx—head and neck cancer	0.000961	0.198	CbGeAlD
Capecitabine—CDA—Pyrimidine metabolism—DPYD—head and neck cancer	0.000947	0.0402	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000883	0.0375	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine metabolism—DPYD—head and neck cancer	0.000757	0.0322	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000734	0.0312	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000651	0.0277	CbGpPWpGaD
Capecitabine—DPYD—Pyrimidine metabolism—TYMS—head and neck cancer	0.000606	0.0257	CbGpPWpGaD
Capecitabine—TYMS—G1/S-Specific Transcription—CCNA1—head and neck cancer	0.000603	0.0256	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000587	0.0249	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000586	0.0249	CbGpPWpGaD
Capecitabine—CDA—Pyrimidine metabolism—TYMS—head and neck cancer	0.00054	0.0229	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000523	0.0222	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000469	0.0199	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000452	0.0192	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000433	0.0184	CbGpPWpGaD
Capecitabine—TYMP—Pyrimidine metabolism—TYMS—head and neck cancer	0.000431	0.0183	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000418	0.0178	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000418	0.0177	CbGpPWpGaD
Capecitabine—TYMS—Pyrimidine metabolism—DPYD—head and neck cancer	0.000387	0.0165	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—DPYD—head and neck cancer	0.000369	0.0157	CbGpPWpGaD
Capecitabine—TYMS—E2F mediated regulation of DNA replication—CCNA1—head and neck cancer	0.000355	0.0151	CbGpPWpGaD
Capecitabine—TYMS—Paclitaxel—Docetaxel—head and neck cancer	0.000335	0.456	CbGdCrCtD
Capecitabine—TYMP—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000334	0.0142	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000308	0.0131	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CEBPA—head and neck cancer	0.000307	0.0131	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.0003	0.0128	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—DPYD—head and neck cancer	0.000295	0.0125	CbGpPWpGaD
Capecitabine—CDA—lymphoid tissue—head and neck cancer	0.000257	0.053	CbGeAlD
Capecitabine—CES1—neck—head and neck cancer	0.000255	0.0526	CbGeAlD
Capecitabine—CES1—E2F transcription factor network—XRCC1—head and neck cancer	0.000251	0.0106	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000247	0.0105	CbGpPWpGaD
Capecitabine—DPYD—thyroid gland—head and neck cancer	0.000243	0.05	CbGeAlD
Capecitabine—TYMP—parotid gland—head and neck cancer	0.00024	0.0496	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CDH1—head and neck cancer	0.000237	0.0101	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—TYMS—head and neck cancer	0.000236	0.01	CbGpPWpGaD
Capecitabine—CDA—thyroid gland—head and neck cancer	0.000233	0.0481	CbGeAlD
Capecitabine—TYMP—saliva-secreting gland—head and neck cancer	0.00023	0.0475	CbGeAlD
Capecitabine—DPYD—Nucleotide metabolism—GPX1—head and neck cancer	0.000223	0.00948	CbGpPWpGaD
Capecitabine—TYMS—Vinorelbine—Vinblastine—head and neck cancer	0.000215	0.293	CbGdCrCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000214	0.00908	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CEBPA—head and neck cancer	0.000213	0.00906	CbGpPWpGaD
Capecitabine—TYMP—connective tissue—head and neck cancer	0.000212	0.0436	CbGeAlD
Capecitabine—CDA—Nucleotide metabolism—TYMS—head and neck cancer	0.00021	0.00893	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—GPX1—head and neck cancer	0.000199	0.00845	CbGpPWpGaD
Capecitabine—TYMS—Vincristine—Vinblastine—head and neck cancer	0.000184	0.251	CbGdCrCtD
Capecitabine—CES1—connective tissue—head and neck cancer	0.000183	0.0377	CbGeAlD
Capecitabine—TYMS—connective tissue—head and neck cancer	0.000182	0.0374	CbGeAlD
Capecitabine—TYMP—trachea—head and neck cancer	0.000178	0.0366	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—CCND1—head and neck cancer	0.000177	0.00752	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—XRCC1—head and neck cancer	0.000174	0.00739	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—TYMS—head and neck cancer	0.000168	0.00714	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—GPX1—head and neck cancer	0.000159	0.00676	CbGpPWpGaD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000156	0.00661	CbGpPWpGaD
Capecitabine—TYMP—lymphoid tissue—head and neck cancer	0.000155	0.0319	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—VEGFA—head and neck cancer	0.000154	0.00656	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—DPYD—head and neck cancer	0.000151	0.00641	CbGpPWpGaD
Capecitabine—DPYD—lymph node—head and neck cancer	0.000151	0.0311	CbGeAlD
Capecitabine—CDA—lymph node—head and neck cancer	0.000145	0.0299	CbGeAlD
Capecitabine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000144	0.0061	CbGpPWpGaD
Capecitabine—TYMP—thyroid gland—head and neck cancer	0.000141	0.029	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—MAPK1—head and neck cancer	0.000139	0.0059	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—EGFR—head and neck cancer	0.000139	0.0059	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000139	0.00589	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CCNA1—head and neck cancer	0.000136	0.00579	CbGpPWpGaD
Capecitabine—CES1—lymphoid tissue—head and neck cancer	0.000134	0.0275	CbGeAlD
Capecitabine—TYMS—lymphoid tissue—head and neck cancer	0.000133	0.0274	CbGeAlD
Capecitabine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000131	0.00555	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—TYMS—head and neck cancer	0.000131	0.00555	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFA—head and neck cancer	0.000128	0.00542	CbGpPWpGaD
Capecitabine—TYMP—head—head and neck cancer	0.000125	0.0257	CbGeAlD
Capecitabine—CES1—thyroid gland—head and neck cancer	0.000121	0.025	CbGeAlD
Capecitabine—TYMS—thyroid gland—head and neck cancer	0.000121	0.0249	CbGeAlD
Capecitabine—TYMP—Bladder Cancer—TP53—head and neck cancer	0.000117	0.00495	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.000115	0.00488	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—HRAS—head and neck cancer	0.000112	0.00474	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000111	0.00471	CbGpPWpGaD
Capecitabine—CES1—head—head and neck cancer	0.000108	0.0222	CbGeAlD
Capecitabine—TYMS—head—head and neck cancer	0.000107	0.0221	CbGeAlD
Capecitabine—DPYD—Metabolism—UROD—head and neck cancer	0.000103	0.00439	CbGpPWpGaD
Capecitabine—CDA—Metabolism—UROD—head and neck cancer	9.2e-05	0.00391	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	8.81e-05	0.00374	CbGpPWpGaD
Capecitabine—TYMP—lymph node—head and neck cancer	8.73e-05	0.018	CbGeAlD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—head and neck cancer	8.18e-05	0.00347	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—GPX1—head and neck cancer	8.14e-05	0.00346	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.69e-05	0.00327	CbGpPWpGaD
Capecitabine—CES1—lymph node—head and neck cancer	7.54e-05	0.0155	CbGeAlD
Capecitabine—TYMS—lymph node—head and neck cancer	7.49e-05	0.0154	CbGeAlD
Capecitabine—CES1—NRF2 pathway—GSTM1—head and neck cancer	7.42e-05	0.00315	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—UROD—head and neck cancer	7.36e-05	0.00313	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.99e-05	0.00297	CbGpPWpGaD
Capecitabine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	6.9e-05	0.00293	CbGpPWpGaD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	6.63e-05	0.00282	CbGpPWpGaD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—head and neck cancer	5.67e-05	0.00241	CbGpPWpGaD
Capecitabine—Cardiac arrest—Fluorouracil—head and neck cancer	5.59e-05	0.00155	CcSEcCtD
Capecitabine—Candida infection—Docetaxel—head and neck cancer	5.59e-05	0.00155	CcSEcCtD
Capecitabine—Skin exfoliation—Docetaxel—head and neck cancer	5.59e-05	0.00155	CcSEcCtD
Capecitabine—Fluid retention—Docetaxel—head and neck cancer	5.55e-05	0.00154	CcSEcCtD
Capecitabine—Ataxia—Fluorouracil—head and neck cancer	5.53e-05	0.00153	CcSEcCtD
Capecitabine—Neuropathy—Docetaxel—head and neck cancer	5.49e-05	0.00152	CcSEcCtD
Capecitabine—Alopecia—Vinblastine—head and neck cancer	5.48e-05	0.00152	CcSEcCtD
Capecitabine—Dry skin—Fluorouracil—head and neck cancer	5.39e-05	0.00149	CcSEcCtD
Capecitabine—Oesophagitis—Docetaxel—head and neck cancer	5.35e-05	0.00148	CcSEcCtD
Capecitabine—Neoplasm—Docetaxel—head and neck cancer	5.29e-05	0.00147	CcSEcCtD
Capecitabine—Nasopharyngitis—Fluorouracil—head and neck cancer	5.26e-05	0.00146	CcSEcCtD
Capecitabine—Muscular weakness—Fluorouracil—head and neck cancer	5.19e-05	0.00144	CcSEcCtD
Capecitabine—Angiopathy—Hydroxyurea—head and neck cancer	5.13e-05	0.00142	CcSEcCtD
Capecitabine—Dysphagia—Fluorouracil—head and neck cancer	5.09e-05	0.00141	CcSEcCtD
Capecitabine—Sepsis—Docetaxel—head and neck cancer	5.08e-05	0.00141	CcSEcCtD
Capecitabine—Chills—Hydroxyurea—head and neck cancer	5.07e-05	0.00141	CcSEcCtD
Capecitabine—Ill-defined disorder—Vinblastine—head and neck cancer	5.01e-05	0.00139	CcSEcCtD
Capecitabine—Alopecia—Hydroxyurea—head and neck cancer	5e-05	0.00139	CcSEcCtD
Capecitabine—Anaemia—Vinblastine—head and neck cancer	4.99e-05	0.00138	CcSEcCtD
Capecitabine—Angina pectoris—Fluorouracil—head and neck cancer	4.95e-05	0.00137	CcSEcCtD
Capecitabine—Phlebitis—Docetaxel—head and neck cancer	4.93e-05	0.00137	CcSEcCtD
Capecitabine—Erythema—Hydroxyurea—head and neck cancer	4.92e-05	0.00136	CcSEcCtD
Capecitabine—Thrombophlebitis—Docetaxel—head and neck cancer	4.91e-05	0.00136	CcSEcCtD
Capecitabine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	4.88e-05	0.00135	CcSEcCtD
Capecitabine—Malaise—Vinblastine—head and neck cancer	4.87e-05	0.00135	CcSEcCtD
Capecitabine—Vertigo—Vinblastine—head and neck cancer	4.85e-05	0.00134	CcSEcCtD
Capecitabine—Leukopenia—Vinblastine—head and neck cancer	4.83e-05	0.00134	CcSEcCtD
Capecitabine—Pancytopenia—Fluorouracil—head and neck cancer	4.83e-05	0.00134	CcSEcCtD
Capecitabine—Swelling—Docetaxel—head and neck cancer	4.81e-05	0.00133	CcSEcCtD
Capecitabine—Deafness—Docetaxel—head and neck cancer	4.75e-05	0.00132	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	4.73e-05	0.00131	CcSEcCtD
Capecitabine—Hepatic failure—Docetaxel—head and neck cancer	4.73e-05	0.00131	CcSEcCtD
Capecitabine—Hypertension—Vinblastine—head and neck cancer	4.66e-05	0.00129	CcSEcCtD
Capecitabine—Photosensitivity reaction—Fluorouracil—head and neck cancer	4.64e-05	0.00129	CcSEcCtD
Capecitabine—Ill-defined disorder—Hydroxyurea—head and neck cancer	4.57e-05	0.00127	CcSEcCtD
Capecitabine—Pneumonia—Fluorouracil—head and neck cancer	4.56e-05	0.00126	CcSEcCtD
Capecitabine—Anaemia—Hydroxyurea—head and neck cancer	4.55e-05	0.00126	CcSEcCtD
Capecitabine—Discomfort—Vinblastine—head and neck cancer	4.54e-05	0.00126	CcSEcCtD
Capecitabine—Hot flush—Docetaxel—head and neck cancer	4.54e-05	0.00126	CcSEcCtD
Capecitabine—Infestation—Fluorouracil—head and neck cancer	4.53e-05	0.00126	CcSEcCtD
Capecitabine—Infestation NOS—Fluorouracil—head and neck cancer	4.53e-05	0.00126	CcSEcCtD
Capecitabine—Menopausal symptoms—Docetaxel—head and neck cancer	4.5e-05	0.00125	CcSEcCtD
Capecitabine—Atrial fibrillation—Docetaxel—head and neck cancer	4.48e-05	0.00124	CcSEcCtD
Capecitabine—Acute coronary syndrome—Fluorouracil—head and neck cancer	4.47e-05	0.00124	CcSEcCtD
Capecitabine—Renal impairment—Docetaxel—head and neck cancer	4.46e-05	0.00124	CcSEcCtD
Capecitabine—Neuropathy peripheral—Fluorouracil—head and neck cancer	4.44e-05	0.00123	CcSEcCtD
Capecitabine—Myocardial infarction—Fluorouracil—head and neck cancer	4.44e-05	0.00123	CcSEcCtD
Capecitabine—Dermatitis bullous—Docetaxel—head and neck cancer	4.44e-05	0.00123	CcSEcCtD
Capecitabine—Malaise—Hydroxyurea—head and neck cancer	4.44e-05	0.00123	CcSEcCtD
Capecitabine—Stomatitis—Fluorouracil—head and neck cancer	4.42e-05	0.00123	CcSEcCtD
Capecitabine—Conjunctivitis—Fluorouracil—head and neck cancer	4.41e-05	0.00122	CcSEcCtD
Capecitabine—Urinary tract infection—Fluorouracil—head and neck cancer	4.41e-05	0.00122	CcSEcCtD
Capecitabine—Leukopenia—Hydroxyurea—head and neck cancer	4.41e-05	0.00122	CcSEcCtD
Capecitabine—Cardiac failure—Docetaxel—head and neck cancer	4.35e-05	0.00121	CcSEcCtD
Capecitabine—Lethargy—Docetaxel—head and neck cancer	4.33e-05	0.0012	CcSEcCtD
Capecitabine—Thrombocytopenia—Vinblastine—head and neck cancer	4.31e-05	0.0012	CcSEcCtD
Capecitabine—DPYD—Metabolism—NAT2—head and neck cancer	4.29e-05	0.00182	CbGpPWpGaD
Capecitabine—Epistaxis—Fluorouracil—head and neck cancer	4.28e-05	0.00119	CcSEcCtD
Capecitabine—Hyponatraemia—Docetaxel—head and neck cancer	4.26e-05	0.00118	CcSEcCtD
Capecitabine—Pain in extremity—Docetaxel—head and neck cancer	4.25e-05	0.00118	CcSEcCtD
Capecitabine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	4.25e-05	0.00118	CcSEcCtD
Capecitabine—Agranulocytosis—Fluorouracil—head and neck cancer	4.23e-05	0.00117	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCNA1—head and neck cancer	4.21e-05	0.00179	CbGpPWpGaD
Capecitabine—Anorexia—Vinblastine—head and neck cancer	4.2e-05	0.00116	CcSEcCtD
Capecitabine—Migraine—Docetaxel—head and neck cancer	4.18e-05	0.00116	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	4.16e-05	0.00115	CcSEcCtD
Capecitabine—Discomfort—Hydroxyurea—head and neck cancer	4.14e-05	0.00115	CcSEcCtD
Capecitabine—Haemoglobin—Fluorouracil—head and neck cancer	4.09e-05	0.00113	CcSEcCtD
Capecitabine—Rhinitis—Fluorouracil—head and neck cancer	4.08e-05	0.00113	CcSEcCtD
Capecitabine—Haemorrhage—Fluorouracil—head and neck cancer	4.07e-05	0.00113	CcSEcCtD
Capecitabine—Hypoaesthesia—Fluorouracil—head and neck cancer	4.05e-05	0.00112	CcSEcCtD
Capecitabine—Pharyngitis—Fluorouracil—head and neck cancer	4.04e-05	0.00112	CcSEcCtD
Capecitabine—Oedema—Hydroxyurea—head and neck cancer	4.02e-05	0.00111	CcSEcCtD
Capecitabine—Ataxia—Docetaxel—head and neck cancer	3.99e-05	0.00111	CcSEcCtD
Capecitabine—Infection—Hydroxyurea—head and neck cancer	3.99e-05	0.00111	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	3.97e-05	0.00168	CbGpPWpGaD
Capecitabine—Paraesthesia—Vinblastine—head and neck cancer	3.96e-05	0.0011	CcSEcCtD
Capecitabine—Dehydration—Docetaxel—head and neck cancer	3.95e-05	0.00109	CcSEcCtD
Capecitabine—Nervous system disorder—Hydroxyurea—head and neck cancer	3.94e-05	0.00109	CcSEcCtD
Capecitabine—Thrombocytopenia—Hydroxyurea—head and neck cancer	3.93e-05	0.00109	CcSEcCtD
Capecitabine—Liver function test abnormal—Docetaxel—head and neck cancer	3.92e-05	0.00109	CcSEcCtD
Capecitabine—Skin disorder—Hydroxyurea—head and neck cancer	3.9e-05	0.00108	CcSEcCtD
Capecitabine—Dry skin—Docetaxel—head and neck cancer	3.89e-05	0.00108	CcSEcCtD
Capecitabine—Orthostatic hypotension—Docetaxel—head and neck cancer	3.88e-05	0.00108	CcSEcCtD
Capecitabine—Abdominal pain upper—Docetaxel—head and neck cancer	3.88e-05	0.00108	CcSEcCtD
Capecitabine—Breast disorder—Docetaxel—head and neck cancer	3.84e-05	0.00106	CcSEcCtD
Capecitabine—Anorexia—Hydroxyurea—head and neck cancer	3.83e-05	0.00106	CcSEcCtD
Capecitabine—Decreased appetite—Vinblastine—head and neck cancer	3.83e-05	0.00106	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	3.82e-05	0.00106	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	3.82e-05	0.00106	CcSEcCtD
Capecitabine—CDA—Metabolism—NAT2—head and neck cancer	3.82e-05	0.00162	CbGpPWpGaD
Capecitabine—Nasopharyngitis—Docetaxel—head and neck cancer	3.8e-05	0.00105	CcSEcCtD
Capecitabine—Pain—Vinblastine—head and neck cancer	3.77e-05	0.00104	CcSEcCtD
Capecitabine—Constipation—Vinblastine—head and neck cancer	3.77e-05	0.00104	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CCNA1—head and neck cancer	3.77e-05	0.0016	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—UROD—head and neck cancer	3.76e-05	0.0016	CbGpPWpGaD
Capecitabine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	3.75e-05	0.00104	CcSEcCtD
Capecitabine—Dysphagia—Docetaxel—head and neck cancer	3.67e-05	0.00102	CcSEcCtD
Capecitabine—Arrhythmia—Fluorouracil—head and neck cancer	3.64e-05	0.00101	CcSEcCtD
Capecitabine—Feeling abnormal—Vinblastine—head and neck cancer	3.63e-05	0.00101	CcSEcCtD
Capecitabine—Bronchospasm—Docetaxel—head and neck cancer	3.61e-05	0.001	CcSEcCtD
Capecitabine—Gastrointestinal pain—Vinblastine—head and neck cancer	3.6e-05	0.000999	CcSEcCtD
Capecitabine—Alopecia—Fluorouracil—head and neck cancer	3.6e-05	0.000997	CcSEcCtD
Capecitabine—Dyspnoea—Hydroxyurea—head and neck cancer	3.58e-05	0.000993	CcSEcCtD
Capecitabine—Angina pectoris—Docetaxel—head and neck cancer	3.58e-05	0.000991	CcSEcCtD
Capecitabine—DPYD—Metabolism—YAP1—head and neck cancer	3.57e-05	0.00152	CbGpPWpGaD
Capecitabine—Erythema—Fluorouracil—head and neck cancer	3.54e-05	0.000982	CcSEcCtD
Capecitabine—Dyspepsia—Hydroxyurea—head and neck cancer	3.54e-05	0.00098	CcSEcCtD
Capecitabine—Decreased appetite—Hydroxyurea—head and neck cancer	3.49e-05	0.000968	CcSEcCtD
Capecitabine—Pancytopenia—Docetaxel—head and neck cancer	3.49e-05	0.000966	CcSEcCtD
Capecitabine—Abdominal pain—Vinblastine—head and neck cancer	3.48e-05	0.000965	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	3.47e-05	0.000961	CcSEcCtD
Capecitabine—Fatigue—Hydroxyurea—head and neck cancer	3.46e-05	0.00096	CcSEcCtD
Capecitabine—Constipation—Hydroxyurea—head and neck cancer	3.44e-05	0.000952	CcSEcCtD
Capecitabine—Pain—Hydroxyurea—head and neck cancer	3.44e-05	0.000952	CcSEcCtD
Capecitabine—Neutropenia—Docetaxel—head and neck cancer	3.43e-05	0.000951	CcSEcCtD
Capecitabine—CDA—Metabolism—DPYD—head and neck cancer	3.35e-05	0.00142	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	3.35e-05	0.00142	CbGpPWpGaD
Capecitabine—Weight increased—Docetaxel—head and neck cancer	3.34e-05	0.000926	CcSEcCtD
Capecitabine—Vision blurred—Fluorouracil—head and neck cancer	3.34e-05	0.000926	CcSEcCtD
Capecitabine—Weight decreased—Docetaxel—head and neck cancer	3.32e-05	0.00092	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	3.31e-05	0.00141	CbGpPWpGaD
Capecitabine—Feeling abnormal—Hydroxyurea—head and neck cancer	3.31e-05	0.000918	CcSEcCtD
Capecitabine—Pneumonia—Docetaxel—head and neck cancer	3.29e-05	0.000912	CcSEcCtD
Capecitabine—Anaemia—Fluorouracil—head and neck cancer	3.27e-05	0.000908	CcSEcCtD
Capecitabine—Infestation NOS—Docetaxel—head and neck cancer	3.27e-05	0.000907	CcSEcCtD
Capecitabine—Infestation—Docetaxel—head and neck cancer	3.27e-05	0.000907	CcSEcCtD
Capecitabine—Hypersensitivity—Vinblastine—head and neck cancer	3.25e-05	0.0009	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	3.24e-05	0.000899	CcSEcCtD
Capecitabine—Acute coronary syndrome—Docetaxel—head and neck cancer	3.23e-05	0.000894	CcSEcCtD
Capecitabine—Renal failure—Docetaxel—head and neck cancer	3.22e-05	0.000892	CcSEcCtD
Capecitabine—Myocardial infarction—Docetaxel—head and neck cancer	3.21e-05	0.000889	CcSEcCtD
Capecitabine—Neuropathy peripheral—Docetaxel—head and neck cancer	3.21e-05	0.000889	CcSEcCtD
Capecitabine—Stomatitis—Docetaxel—head and neck cancer	3.19e-05	0.000884	CcSEcCtD
Capecitabine—Jaundice—Docetaxel—head and neck cancer	3.19e-05	0.000884	CcSEcCtD
Capecitabine—Conjunctivitis—Docetaxel—head and neck cancer	3.18e-05	0.000882	CcSEcCtD
Capecitabine—CDA—Metabolism—YAP1—head and neck cancer	3.18e-05	0.00135	CbGpPWpGaD
Capecitabine—Body temperature increased—Hydroxyurea—head and neck cancer	3.18e-05	0.00088	CcSEcCtD
Capecitabine—Leukopenia—Fluorouracil—head and neck cancer	3.17e-05	0.000879	CcSEcCtD
Capecitabine—Asthenia—Vinblastine—head and neck cancer	3.16e-05	0.000876	CcSEcCtD
Capecitabine—Hepatobiliary disease—Docetaxel—head and neck cancer	3.09e-05	0.000858	CcSEcCtD
Capecitabine—Epistaxis—Docetaxel—head and neck cancer	3.09e-05	0.000856	CcSEcCtD
Capecitabine—TYMP—Metabolism—NAT2—head and neck cancer	3.06e-05	0.0013	CbGpPWpGaD
Capecitabine—Agranulocytosis—Docetaxel—head and neck cancer	3.05e-05	0.000847	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—RAD51—head and neck cancer	3.03e-05	0.00129	CbGpPWpGaD
Capecitabine—Chest pain—Fluorouracil—head and neck cancer	3.02e-05	0.000836	CcSEcCtD
Capecitabine—Myalgia—Fluorouracil—head and neck cancer	3.02e-05	0.000836	CcSEcCtD
Capecitabine—Diarrhoea—Vinblastine—head and neck cancer	3.01e-05	0.000836	CcSEcCtD
Capecitabine—Discomfort—Fluorouracil—head and neck cancer	2.98e-05	0.000826	CcSEcCtD
Capecitabine—Hypersensitivity—Hydroxyurea—head and neck cancer	2.96e-05	0.000821	CcSEcCtD
Capecitabine—Haemoglobin—Docetaxel—head and neck cancer	2.95e-05	0.000819	CcSEcCtD
Capecitabine—Rhinitis—Docetaxel—head and neck cancer	2.95e-05	0.000816	CcSEcCtD
Capecitabine—Haemorrhage—Docetaxel—head and neck cancer	2.94e-05	0.000814	CcSEcCtD
Capecitabine—Hepatitis—Docetaxel—head and neck cancer	2.94e-05	0.000814	CcSEcCtD
Capecitabine—Hypoaesthesia—Docetaxel—head and neck cancer	2.92e-05	0.00081	CcSEcCtD
Capecitabine—Confusional state—Fluorouracil—head and neck cancer	2.92e-05	0.000808	CcSEcCtD
Capecitabine—Pharyngitis—Docetaxel—head and neck cancer	2.92e-05	0.000808	CcSEcCtD
Capecitabine—Dizziness—Vinblastine—head and neck cancer	2.91e-05	0.000808	CcSEcCtD
Capecitabine—Urinary tract disorder—Docetaxel—head and neck cancer	2.9e-05	0.000804	CcSEcCtD
Capecitabine—Oedema peripheral—Docetaxel—head and neck cancer	2.89e-05	0.000802	CcSEcCtD
Capecitabine—Oedema—Fluorouracil—head and neck cancer	2.89e-05	0.000802	CcSEcCtD
Capecitabine—Connective tissue disorder—Docetaxel—head and neck cancer	2.89e-05	0.0008	CcSEcCtD
Capecitabine—Asthenia—Hydroxyurea—head and neck cancer	2.88e-05	0.000799	CcSEcCtD
Capecitabine—Urethral disorder—Docetaxel—head and neck cancer	2.88e-05	0.000798	CcSEcCtD
Capecitabine—Infection—Fluorouracil—head and neck cancer	2.87e-05	0.000796	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.87e-05	0.00122	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.86e-05	0.00122	CbGpPWpGaD
Capecitabine—Nervous system disorder—Fluorouracil—head and neck cancer	2.84e-05	0.000786	CcSEcCtD
Capecitabine—Thrombocytopenia—Fluorouracil—head and neck cancer	2.83e-05	0.000785	CcSEcCtD
Capecitabine—Visual impairment—Docetaxel—head and neck cancer	2.83e-05	0.000785	CcSEcCtD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.83e-05	0.0012	CbGpPWpGaD
Capecitabine—Tachycardia—Fluorouracil—head and neck cancer	2.82e-05	0.000782	CcSEcCtD
Capecitabine—Vomiting—Vinblastine—head and neck cancer	2.8e-05	0.000776	CcSEcCtD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CCND1—head and neck cancer	2.79e-05	0.00119	CbGpPWpGaD
Capecitabine—Erythema multiforme—Docetaxel—head and neck cancer	2.78e-05	0.00077	CcSEcCtD
Capecitabine—Headache—Vinblastine—head and neck cancer	2.76e-05	0.000765	CcSEcCtD
Capecitabine—Anorexia—Fluorouracil—head and neck cancer	2.76e-05	0.000764	CcSEcCtD
Capecitabine—Diarrhoea—Hydroxyurea—head and neck cancer	2.75e-05	0.000762	CcSEcCtD
Capecitabine—Eye disorder—Docetaxel—head and neck cancer	2.75e-05	0.000761	CcSEcCtD
Capecitabine—Cardiac disorder—Docetaxel—head and neck cancer	2.73e-05	0.000756	CcSEcCtD
Capecitabine—Flushing—Docetaxel—head and neck cancer	2.73e-05	0.000756	CcSEcCtD
Capecitabine—Hypotension—Fluorouracil—head and neck cancer	2.7e-05	0.000749	CcSEcCtD
Capecitabine—TYMP—Metabolism—DPYD—head and neck cancer	2.68e-05	0.00114	CbGpPWpGaD
Capecitabine—Angiopathy—Docetaxel—head and neck cancer	2.67e-05	0.000739	CcSEcCtD
Capecitabine—Dizziness—Hydroxyurea—head and neck cancer	2.66e-05	0.000736	CcSEcCtD
Capecitabine—Immune system disorder—Docetaxel—head and neck cancer	2.65e-05	0.000736	CcSEcCtD
Capecitabine—Mediastinal disorder—Docetaxel—head and neck cancer	2.65e-05	0.000734	CcSEcCtD
Capecitabine—Chills—Docetaxel—head and neck cancer	2.64e-05	0.000731	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	2.63e-05	0.00073	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	2.63e-05	0.00112	CbGpPWpGaD
Capecitabine—Arrhythmia—Docetaxel—head and neck cancer	2.62e-05	0.000728	CcSEcCtD
Capecitabine—Nausea—Vinblastine—head and neck cancer	2.62e-05	0.000725	CcSEcCtD
Capecitabine—Insomnia—Fluorouracil—head and neck cancer	2.62e-05	0.000725	CcSEcCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	2.61e-05	0.00111	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	2.6e-05	0.0011	CbGpPWpGaD
Capecitabine—Paraesthesia—Fluorouracil—head and neck cancer	2.6e-05	0.00072	CcSEcCtD
Capecitabine—Alopecia—Docetaxel—head and neck cancer	2.6e-05	0.00072	CcSEcCtD
Capecitabine—Dyspnoea—Fluorouracil—head and neck cancer	2.58e-05	0.000715	CcSEcCtD
Capecitabine—Mental disorder—Docetaxel—head and neck cancer	2.57e-05	0.000713	CcSEcCtD
Capecitabine—Erythema—Docetaxel—head and neck cancer	2.56e-05	0.000709	CcSEcCtD
Capecitabine—Malnutrition—Docetaxel—head and neck cancer	2.56e-05	0.000709	CcSEcCtD
Capecitabine—Vomiting—Hydroxyurea—head and neck cancer	2.55e-05	0.000708	CcSEcCtD
Capecitabine—Dyspepsia—Fluorouracil—head and neck cancer	2.55e-05	0.000706	CcSEcCtD
Capecitabine—TYMP—Metabolism—YAP1—head and neck cancer	2.54e-05	0.00108	CbGpPWpGaD
Capecitabine—Rash—Hydroxyurea—head and neck cancer	2.53e-05	0.000702	CcSEcCtD
Capecitabine—Dermatitis—Hydroxyurea—head and neck cancer	2.53e-05	0.000702	CcSEcCtD
Capecitabine—Headache—Hydroxyurea—head and neck cancer	2.52e-05	0.000698	CcSEcCtD
Capecitabine—Decreased appetite—Fluorouracil—head and neck cancer	2.51e-05	0.000697	CcSEcCtD
Capecitabine—Dysgeusia—Docetaxel—head and neck cancer	2.5e-05	0.000694	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	2.5e-05	0.000692	CcSEcCtD
Capecitabine—Back pain—Docetaxel—head and neck cancer	2.47e-05	0.000686	CcSEcCtD
Capecitabine—Pain—Fluorouracil—head and neck cancer	2.47e-05	0.000686	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.46e-05	0.00105	CbGpPWpGaD
Capecitabine—Muscle spasms—Docetaxel—head and neck cancer	2.46e-05	0.000682	CcSEcCtD
Capecitabine—Nausea—Hydroxyurea—head and neck cancer	2.39e-05	0.000662	CcSEcCtD
Capecitabine—Feeling abnormal—Fluorouracil—head and neck cancer	2.38e-05	0.000661	CcSEcCtD
Capecitabine—Anaemia—Docetaxel—head and neck cancer	2.36e-05	0.000655	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.34e-05	0.000994	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.32e-05	0.000986	CbGpPWpGaD
Capecitabine—Urticaria—Fluorouracil—head and neck cancer	2.3e-05	0.000637	CcSEcCtD
Capecitabine—Syncope—Docetaxel—head and neck cancer	2.29e-05	0.000636	CcSEcCtD
Capecitabine—Leukopenia—Docetaxel—head and neck cancer	2.29e-05	0.000635	CcSEcCtD
Capecitabine—Body temperature increased—Fluorouracil—head and neck cancer	2.29e-05	0.000634	CcSEcCtD
Capecitabine—Palpitations—Docetaxel—head and neck cancer	2.26e-05	0.000626	CcSEcCtD
Capecitabine—Loss of consciousness—Docetaxel—head and neck cancer	2.25e-05	0.000623	CcSEcCtD
Capecitabine—Cough—Docetaxel—head and neck cancer	2.23e-05	0.000619	CcSEcCtD
Capecitabine—Hypertension—Docetaxel—head and neck cancer	2.21e-05	0.000612	CcSEcCtD
Capecitabine—Arthralgia—Docetaxel—head and neck cancer	2.18e-05	0.000604	CcSEcCtD
Capecitabine—Chest pain—Docetaxel—head and neck cancer	2.18e-05	0.000604	CcSEcCtD
Capecitabine—Myalgia—Docetaxel—head and neck cancer	2.18e-05	0.000604	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	2.16e-05	0.000599	CcSEcCtD
Capecitabine—DPYD—Metabolism—TYMS—head and neck cancer	2.14e-05	0.00091	CbGpPWpGaD
Capecitabine—Hypersensitivity—Fluorouracil—head and neck cancer	2.13e-05	0.000591	CcSEcCtD
Capecitabine—Dry mouth—Docetaxel—head and neck cancer	2.13e-05	0.00059	CcSEcCtD
Capecitabine—DPYD—Metabolism—GSTM1—head and neck cancer	2.12e-05	0.0009	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.11e-05	0.000898	CbGpPWpGaD
Capecitabine—Confusional state—Docetaxel—head and neck cancer	2.1e-05	0.000583	CcSEcCtD
Capecitabine—Oedema—Docetaxel—head and neck cancer	2.09e-05	0.000579	CcSEcCtD
Capecitabine—Infection—Docetaxel—head and neck cancer	2.07e-05	0.000575	CcSEcCtD
Capecitabine—Shock—Docetaxel—head and neck cancer	2.05e-05	0.000569	CcSEcCtD
Capecitabine—Nervous system disorder—Docetaxel—head and neck cancer	2.05e-05	0.000567	CcSEcCtD
Capecitabine—Pruritus—Fluorouracil—head and neck cancer	2.05e-05	0.000567	CcSEcCtD
Capecitabine—Thrombocytopenia—Docetaxel—head and neck cancer	2.04e-05	0.000566	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.04e-05	0.000867	CbGpPWpGaD
Capecitabine—Tachycardia—Docetaxel—head and neck cancer	2.04e-05	0.000565	CcSEcCtD
Capecitabine—DPYD—Metabolism—GPX1—head and neck cancer	2.03e-05	0.000861	CbGpPWpGaD
Capecitabine—Skin disorder—Docetaxel—head and neck cancer	2.03e-05	0.000562	CcSEcCtD
Capecitabine—DPYD—Metabolism—CYP1A1—head and neck cancer	2.01e-05	0.000853	CbGpPWpGaD
Capecitabine—Anorexia—Docetaxel—head and neck cancer	1.99e-05	0.000552	CcSEcCtD
Capecitabine—Diarrhoea—Fluorouracil—head and neck cancer	1.98e-05	0.000548	CcSEcCtD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	1.97e-05	0.000837	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—head and neck cancer	1.96e-05	0.000832	CbGpPWpGaD
Capecitabine—Hypotension—Docetaxel—head and neck cancer	1.95e-05	0.000541	CcSEcCtD
Capecitabine—Dizziness—Fluorouracil—head and neck cancer	1.91e-05	0.00053	CcSEcCtD
Capecitabine—CDA—Metabolism—TYMS—head and neck cancer	1.91e-05	0.000811	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	1.9e-05	0.000527	CcSEcCtD
Capecitabine—Insomnia—Docetaxel—head and neck cancer	1.89e-05	0.000523	CcSEcCtD
Capecitabine—CDA—Metabolism—GSTM1—head and neck cancer	1.89e-05	0.000802	CbGpPWpGaD
Capecitabine—Paraesthesia—Docetaxel—head and neck cancer	1.87e-05	0.00052	CcSEcCtD
Capecitabine—Dyspnoea—Docetaxel—head and neck cancer	1.86e-05	0.000516	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.84e-05	0.000783	CbGpPWpGaD
Capecitabine—Vomiting—Fluorouracil—head and neck cancer	1.84e-05	0.00051	CcSEcCtD
Capecitabine—Dyspepsia—Docetaxel—head and neck cancer	1.84e-05	0.000509	CcSEcCtD
Capecitabine—Rash—Fluorouracil—head and neck cancer	1.82e-05	0.000505	CcSEcCtD
Capecitabine—Dermatitis—Fluorouracil—head and neck cancer	1.82e-05	0.000505	CcSEcCtD
Capecitabine—Decreased appetite—Docetaxel—head and neck cancer	1.81e-05	0.000503	CcSEcCtD
Capecitabine—Headache—Fluorouracil—head and neck cancer	1.81e-05	0.000502	CcSEcCtD
Capecitabine—CDA—Metabolism—GPX1—head and neck cancer	1.81e-05	0.000768	CbGpPWpGaD
Capecitabine—Gastrointestinal disorder—Docetaxel—head and neck cancer	1.8e-05	0.0005	CcSEcCtD
Capecitabine—Fatigue—Docetaxel—head and neck cancer	1.8e-05	0.000499	CcSEcCtD
Capecitabine—CDA—Metabolism—CYP1A1—head and neck cancer	1.79e-05	0.00076	CbGpPWpGaD
Capecitabine—Pain—Docetaxel—head and neck cancer	1.78e-05	0.000495	CcSEcCtD
Capecitabine—Constipation—Docetaxel—head and neck cancer	1.78e-05	0.000495	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.74e-05	0.000741	CbGpPWpGaD
Capecitabine—Feeling abnormal—Docetaxel—head and neck cancer	1.72e-05	0.000477	CcSEcCtD
Capecitabine—Nausea—Fluorouracil—head and neck cancer	1.72e-05	0.000476	CcSEcCtD
Capecitabine—Gastrointestinal pain—Docetaxel—head and neck cancer	1.71e-05	0.000473	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.66e-05	0.000705	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.66e-05	0.000705	CbGpPWpGaD
Capecitabine—Abdominal pain—Docetaxel—head and neck cancer	1.65e-05	0.000457	CcSEcCtD
Capecitabine—Body temperature increased—Docetaxel—head and neck cancer	1.65e-05	0.000457	CcSEcCtD
Capecitabine—TYMS—Metabolism—NAT2—head and neck cancer	1.56e-05	0.000664	CbGpPWpGaD
Capecitabine—Hypersensitivity—Docetaxel—head and neck cancer	1.54e-05	0.000426	CcSEcCtD
Capecitabine—TYMP—Metabolism—TYMS—head and neck cancer	1.53e-05	0.000648	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—head and neck cancer	1.51e-05	0.000641	CbGpPWpGaD
Capecitabine—Asthenia—Docetaxel—head and neck cancer	1.5e-05	0.000415	CcSEcCtD
Capecitabine—Pruritus—Docetaxel—head and neck cancer	1.48e-05	0.000409	CcSEcCtD
Capecitabine—TYMP—Metabolism—GPX1—head and neck cancer	1.45e-05	0.000614	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.44e-05	0.000612	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP1A1—head and neck cancer	1.43e-05	0.000608	CbGpPWpGaD
Capecitabine—Diarrhoea—Docetaxel—head and neck cancer	1.43e-05	0.000396	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.39e-05	0.000592	CbGpPWpGaD
Capecitabine—Dizziness—Docetaxel—head and neck cancer	1.38e-05	0.000383	CcSEcCtD
Capecitabine—TYMS—Metabolism—DPYD—head and neck cancer	1.37e-05	0.000582	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—head and neck cancer	1.34e-05	0.000568	CbGpPWpGaD
Capecitabine—Vomiting—Docetaxel—head and neck cancer	1.33e-05	0.000368	CcSEcCtD
Capecitabine—Rash—Docetaxel—head and neck cancer	1.32e-05	0.000365	CcSEcCtD
Capecitabine—Dermatitis—Docetaxel—head and neck cancer	1.31e-05	0.000364	CcSEcCtD
Capecitabine—Headache—Docetaxel—head and neck cancer	1.31e-05	0.000362	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	1.3e-05	0.000553	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—YAP1—head and neck cancer	1.3e-05	0.000552	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	1.28e-05	0.000545	CbGpPWpGaD
Capecitabine—Nausea—Docetaxel—head and neck cancer	1.24e-05	0.000344	CcSEcCtD
Capecitabine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	1.23e-05	0.000524	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	1.22e-05	0.000517	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—head and neck cancer	1.19e-05	0.000507	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.18e-05	0.0005	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—UROD—head and neck cancer	1.08e-05	0.000461	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—head and neck cancer	1.06e-05	0.000452	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—head and neck cancer	1.04e-05	0.000442	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CCND1—head and neck cancer	1.02e-05	0.000435	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTEN—head and neck cancer	9.28e-06	0.000394	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CCND1—head and neck cancer	9.15e-06	0.000389	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—head and neck cancer	8.51e-06	0.000361	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—head and neck cancer	8.44e-06	0.000359	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.42e-06	0.000358	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK1—head and neck cancer	8.03e-06	0.000341	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—head and neck cancer	7.72e-06	0.000328	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK3—head and neck cancer	7.55e-06	0.000321	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—head and neck cancer	7.42e-06	0.000315	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—head and neck cancer	7.39e-06	0.000314	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CA—head and neck cancer	7.35e-06	0.000312	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP1A1—head and neck cancer	7.32e-06	0.000311	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK1—head and neck cancer	7.18e-06	0.000305	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CA—head and neck cancer	6.55e-06	0.000278	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—head and neck cancer	6.03e-06	0.000256	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—head and neck cancer	6e-06	0.000255	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—head and neck cancer	5.35e-06	0.000227	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CA—head and neck cancer	5.23e-06	0.000222	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.78e-06	0.000203	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.74e-06	0.000201	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAT2—head and neck cancer	4.51e-06	0.000191	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—head and neck cancer	4.35e-06	0.000185	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—head and neck cancer	4.28e-06	0.000182	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—DPYD—head and neck cancer	3.95e-06	0.000168	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—head and neck cancer	3.8e-06	0.000161	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—YAP1—head and neck cancer	3.75e-06	0.000159	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.82e-06	0.00012	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CA—head and neck cancer	2.68e-06	0.000114	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.46e-06	0.000104	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TYMS—head and neck cancer	2.25e-06	9.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.23e-06	9.45e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—head and neck cancer	2.19e-06	9.29e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—head and neck cancer	2.13e-06	9.05e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.11e-06	8.96e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.73e-06	7.36e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.25e-06	5.33e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.09e-06	4.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.72e-07	3.28e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—head and neck cancer	6.3e-07	2.68e-05	CbGpPWpGaD
